Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With ADRD

Indiana University60 enrolled

Overview

The purpose of the study is to test if Acceptance and Commitment Therapy (ACT), a behavioral intervention designed to increase psychological flexibility in the face of challenges, reduces anxiety associated psychological distress in dementia caregivers compared to the control group who will receive self-help and educational materials. This version of ACT is delivered over the phone in six primary sessions and one booster session.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Anxiety Caregiver Burden

Interventions

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults with Alzheimer's Disease and Related DementiasBEHAVIORAL

A telephone-based acceptance and commitment therapy for caregivers

Eligibility

Sex: ALLMin age: 21 YearsMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Listed in ADRD patient's chart as primary caregiver or self-identifies as ADRD patient's primary caregiver * Intends to continue caregiving for ≥12 months * Clinically-significant anxiety (score ≥10 on GAD-7) * 21 years or older * Able to communicate in English * Able to provide informed consent Exclusion Criteria: * Caregiver is a non-family member * Care recipient is in an assisted living or nursing home (at baseline) * Has ADRD or other serious mental illness diagnosis such as schizophrenia as determined by ICD-10 code or self-report * Caregiver is enrolled in an existing ADRD collaborative program at Eskenazi Health, IU Health or the VA. * Caregiver is enrolled in another IU study that is testing a ADRD caregiver intervention

Locations (1)

IUH

Indianapolis, Indiana, United States

Outcomes

Primary Outcomes

Generalized Anxiety Disorder Scale (GAD-7)

The Generalized Anxiety Disorder Scale (GAD-7) contains 7 items with total scores ranging from 0 to 21. Scores of 5, 10, and 15 are cut-offs for mild, moderate, and severe anxiety, respectively. An add-on item assessing the patient's global impression of symptom-related impairment helps researchers understand the extent to which anxiety interferes in daily life. The GAD-7 has factorial validity for the diagnosis of general anxiety disorder and is sensitive to change.

Time frame: Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.